Holen Sie sich die Stockscreener-App
9.98
1.29%
-0.13
Schlusskurs vom Vortag:
$10.11
Offen:
$9.98
24-Stunden-Volumen:
1.36M
Relative Volume:
0.74
Marktkapitalisierung:
$1.46B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-174.61M
KGV:
-5.066
EPS:
-1.97
Netto-Cashflow:
$-165.54M
1W Leistung:
-5.04%
1M Leistung:
-0.99%
6M Leistung:
+47.85%
1J Leistung:
+20.10%
1-Tages-Spanne:
$9.815
$10.26
1-Wochen-Bereich:
$9.815
$10.85
52-Wochen-Spanne:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Firmenname
89 Bio Inc
Sektor
Branche
Telefon
(415) 432-9270
Adresse
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Vergleichen Sie ETNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
9.98 | 1.53B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-14 | Eingeleitet | Goldman | Neutral |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-04-22 | Fortgesetzt | BofA Securities | Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Eingeleitet | UBS | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2022-05-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-26 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Eingeleitet | Raymond James | Strong Buy |
| 2020-09-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-23 | Eingeleitet | BTIG Research | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-12-09 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2019-12-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-12-09 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
89BIO (NASDAQ:ETNB) Receives $26.43 Consensus Price Target from Brokerages - Defense World
Is 89bio Inc. a good long term investmentFree Stock Market Mentorship - jammulinksnews.com
What analysts say about 89bio Inc. stockFree Stock Market Trend Analysis - jammulinksnews.com
What makes 89bio Inc. stock price move sharplyRisk Managed Trading Strategy - beatles.ru
What drives 89bio Inc. stock priceGame-changing returns - jammulinksnews.com
Teacher Retirement System of Texas Raises Stock Position in 89BIO (NASDAQ:ETNB) - Defense World
89bio Inc. Stock Analysis and ForecastExceptional stock performance - jammulinksnews.com
89bio exec Le-Nguyen sells $115k in stock By Investing.com - Investing.com South Africa
89bio exec Le-Nguyen sells $115k in stock - Investing.com Australia
Why 89bio Inc. stock attracts strong analyst attentionFree Consultation - Newser
How 89bio Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser
89BIO (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga
Transcript : 89bio, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10 - MarketScreener
89BIO (NASDAQ:ETNB) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
89bio, Inc.(NasdaqGM: ETNB) added to Russell 3000E Growth Index - MarketScreener
89bio, Inc.(NasdaqGM: ETNB) added to Russell 3000 Growth Index - MarketScreener
Brokerages Set 89BIO (NASDAQ:ETNB) Price Target at $26.43 - Defense World
89BIO’s (ETNB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
89bio Inc (ETNB Stock: A Sea of Opportunity - investchronicle.com
Assenagon Asset Management S.A. Increases Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
California State Teachers Retirement System Increases Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Cantor Fitzgerald Estimates 89bio FY2026 Earnings - Defense World
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Transcript : 89bio, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11 - MarketScreener
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress - Yahoo Finance
89bio, Inc. (NASDAQ:ETNB) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Ameriprise Financial Inc. Has $221,000 Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89Bio Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News - GuruFocus
89bio Expands Team with 61,100 Share Options Grant to Key New Hires - Stock Titan
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
89bio Showcases Liver Disease Pipeline at Goldman Sachs Healthcare Conference Next Week - Stock Titan
Finanzdaten der 89 Bio Inc-Aktie (ETNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):